Analysis of cognitive status in patients with type 2 diabetes

Background: Cognitive impairment is a common complication of type 2 diabetes, greatly reduce the quality of life and daily functioning of patients, as well as have an impact on their compliance to therapy.

Aim: Explore the nature and frequency of cognitive impairment in patients with type 2 diabetes, their relation to carbohydrate metabolism.

Materials and methods: The study involved 113 patients with type 2 diabetes aged 40–70 years, with disease duration of more than 12 months; Control group consisted of 33 persons, stateless persons with type 2 diabetes, matched by age, sex, level of education, the presence of cardiovascular diseases such as hypertension and coronary heart disease. The complex included a survey of clinical and laboratory tests, instrumental, neuropsychological testing. To screen for cognitive impairment used by the Montreal Cognitive Assessment Scale (MоСа test), for the study of the frontal functions FAB (frontal dysfunction battery).

Results: The study of cognitive impairment were diagnosed in 53,1 ± 9,2% of patients with type 2 diabetes, which is statistically significantly higher than in those in the control group 15,2 ± 12,2%. In patients with type 2 diabetes prevailed violations fronto-subcortical type with a reduction in short-term memory function, attention and constructive praxis. Cognitive impairment correlated with indices of carbohydrate metabolism (HbA1c, fasting glucose), disease duration 7 [5, 12] years and the patient's.

Conclusions: These data confirm the impact of hyperglycemia as a major pathogenic factor and duration of the disease on the formation and progression of cognitive impairment in patients with type 2 diabetes.

type 2 diabetes, cognitive impairment, neuropsychological testing, MoСа-test

1. Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом / Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. – 8-й выпуск // Сахарный диабет. – 2017. – Т. 20. – №1S. – C. 1-121. [Dedov II, Shestakova MV, Mayorov AY, Vikulova OK, Galstyan GR, Kuraeva TL, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition. Diabetes mellitus. 2017;20(1S):1-121. (In Russ.)] doi: 10.14341/DM8146

2. Липатов Д.В., Александрова В.К., Атарщиков Д.С., и др. Эпидемиология и регистр диабетической ретинопатии в Российской Федерации // Сахарный диабет. – 2014. – Т. 17. – №1. – C. 4-7. // [Lipatov DV, Aleksandrova VK, Atarshchikov DS, et al. Current report from Russian Diabetic Retinopathy Register. Diabetes mellitus. 2014;17(1):4-7. (In Russ.)] doi: 10.14341/DM201414-7

3. Сунцов Ю.И., Болотская Л.Л., Маслова О.В., Казаков И.В. Эпидемиология сахарного диабета и прогноз его распространенности в Российской Федерации // Сахарный диабет. – 2011. – Т. 14. – №1. – С. 15–19. [Suntsov YI, Bolotskaya LL, Maslova OV, Kazakov IV. Epidemiology of diabetes mellitus and prognosis of its prevalence in the Russian Federation. Diabetes mellitus. 2011;14(1):15-19. (In Russ.)] doi: 10.14341/2072-0351-6245

4. Гацких И.В., Веселова О.Ф., Брикман И.Н., и др. Когнитивные нарушения при сахарном диабете 2 типа // Современные проблемы науки и образования. – 2015. – №4. – С. 344-352. [Gatckikh IV, Veselova OF, Brickman IN, et al. Cognitive impairments in type 2 diabetes. Modern problems of science and education. 2015;(4):344-352. (In Russ.)]

5. Маркин С.П. Поражение нервной системы у пациентов с сахарным диабетом // Журнал неврологии и психиатрии им. С.С. Корсакова. – 2012. – Т. 112. – №5. – С.77-80. [Markin SP The defeat of the nervous system in patients with diabetes mellitus. Zhurnal nevrologii i psikhiatrii. 2012;112(5):77-80. (In Russ.)]

6. Петрова М.М., Прокопенко С.В., Пронина Е.А. Когнитивные и эмоциональные нарушения у пациентов с сахарным диабетом 2 типа // Сибирское медицинское обозрение. – 2008. – Т. 52. – №4. – С. 83-85. [Petrova MM, Prokopenko SV, Pronina EA. Cognitive and emotional disorders in patients with type 2 diabetes. Sibirskoe meditsinskoe obozrenie. 2008;52(4):83-85. (InRuss.)]

7. Товажнянская Е.Л., Безуглова И.О., Наврузов М.Б., и др. Умеренные когнитивные нарушения при сахарном диабете 2-го типа // Международный медицинский журнал. – 2012. – №1. – С. 6-9. [Tovazhnyanskaya EL, Bezuglova IO, Navruzov MB, et al. Mild cognitive impairment in type 2 diabetes. International medical journal. 2012;(1):6-9. (In Russ.)]

8. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia. Arch Neurol. 2009;66(3):300–305. doi: 10.1001/archneurol.2009.27

9. Yaffe K, Falvey C, Hamilton N, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69(9):1170–1175. doi: 10.1001/archneurol.2012.1117

10. Biessels GJ, Strachan MW, Visseren FL, et al. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2(3):246–255. doi: 10.1016/S2213-8587(13)70088-3

11. Brookmeyer R, Evans DA, Hebert L, et al. National estimates of the prevalence of Alzheimer’s disease in the United States. Alzheimers Dement. 2011;7(1):61–73. doi: 10.1016/j.jalz.2010.11.007

12. Wennberg AM, Gottesman RF, Kaufmann CN, et al. Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends Study. Int Psychogeriatr. 2014;26(10):1729–1735. doi: 10.1017/S1041610214001380

13. Li J, Shao YH, Gong YP, et al. Diabetes mellitus and dementia – a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2014;18(12):1778–1789.

14. Васенина Е.Е., Левин О.С. Когнитивные нарушения у пациентов с сахарным диабетом 2 типа // Эффективная фармакотерапия. Эндокринология. – 2016. – №3. – С. 40-47. [Vasenina YY, Levin OS. Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. Effective Pharmacotherapy. Endocrinology. 2016;(3):40-47.(In Russ.)]

15. Sanz C, Andrieu S, Sinclair A, et al. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology. 2009;73(17):1359–1366. doi: 10.1212/wnl.0b013e3181bd80e9

16. Сторостина Е.Г., Володина М.Н. Церебральная ишемия как маркер депрессии и когнитивных нарушений при сахарном диабете 2 типа // Сахарный диабет. – 2010. – Т. 13. – №4. – С. 117-118. [Starostina EG, Volodina MN. Cerebralischemia as a marker of depression and cognitive disorders in patients with type 2 diabetes mellitus. Diabetes mellitus. 2010;13(4):117-118. (In Russ.)] doi: 10.14341/2072-0351-6073

17. Старостина Е.Г., Володина М.Н., Бобров А.Е. Клинико-лабораторные корреляты уровня интеллекта (IQ) у больных сахарным диабетом 2 типа и ожирением. // Альманах клинической медицины. – 2015. – №S1. – С. 87-94. [Starostina EG, Volodina MN, Bobrov AE. Clinical and laboratory correlates of intelligence level (IQ) in patients with type 2 diabetes and obesity. Al’manah kliniceskoj mediciny. 2015;(S1):87-94. (In Russ.)] doi: 10.18786/2072-0505-2015-1-87-94

18. Strachan MWJ, Reynolds RM, Frier BM, et al. The relationship between type 2 diabetes and dementia. British Medical Bulletin. 2008;88(1):131-146. doi: 10.1093/bmb/ldn042

19. Mijnhout GS, Scheltens P, Diamant M, et al. Diabetic encephalopathy: a concept in need of a definition. Diabetologia. 2006;49(6):1447-1448. doi: 10.1007/s00125-006-0221-8

20. Nelson PT, Smith CD, Abner EA, et al. Human cerebral neuropathology of type 2 diabetes mellitus. Biochim Biophys Acta. 2008;1792(5):454-469. doi: 10.1016/j.bbadis.2008.08.005

21. Whitmer RA, Karter AJ, Yafe K, et al. Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus. JAMA. 2009;301(15):1565-1572. doi: 10.1001/jama.2009.460

22. Zilkens RR, Davis WA, Spilsbury K, et al. Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. Am J Epidemiol. 2013;177(11):1246–1254. doi: 10.1093/aje/kws387

23. Sinclair AJ, Paolisso G, Castro M, et al. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab. 2011;37(Suppl 3):27–38. doi: 10.1016/S1262-3636(11)70962-4

24. Roriz-Filho JS, Sá-Roriz TM, Rosset I, et al. (Pre) diabetes, brain aging, and cognition. Biochim Biophys Acta. 2009;1792(5):432-443. doi: 10.1016/j.bbadis.2008.12.003

25. Захаров В.В., Вознесенская Т.Г. Нервно-психические нарушения: диагностические тесты. – М.: МЕДпресс-информ, 2013. [Zakharov VV, Voznesenskaya TG. Nervno-psikhicheskie narusheniya: diagnosticheskie testy. Moscow: MEDpress-inform; 2013ç (In Russ.)]

26. Чумакова Г.А., Веселовская Н.Г., Гриценко О.В, Отт А.В. Метаболический синдром: сложные и нерешенные проблемы // Российский кардиологический журнал. – 2014. – №3. – С. 63-71. [Chumakova GA, Veselovskaya NG, Gritsenko OV, Ott AV. Metabolic syndrome: challenging and unresolved issues. Russ J Cardiol. 2014;(3): 63-71. (In Russ.)]

27. Yoon DH, Choi SH, Yu JH, et al. The relationship between visceral adiposity and cognitive performance in older adults. Age Ageing. 2012;41(4):456-461. doi: 10.1093/ageing/afs018

28. Freitas S, Simoes MR, Maroco J, et al Construct validity of the Montreal Cognitive Assessment (MoCa). J Int Neuropsychol Soc. 2012;18(2):242-250. doi: 10.1017/S1355617711001573

29. Яхно Н.Н., Захаров В.В. Легкие когнитивные нарушения в пожилом возрасте // Неврологический журнал. – 2004. – Т. 9. – №1. – С.4-8. [Yakhno NN, Zakharov VV. Legkie kognitivnye narusheniya v pozhilom vozraste. Nevrologicheskiy zhurnal. 2004;9(1):4-8. (In Russ.)]

30. Kold CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev. 2008;29(4):494–511. doi: 10.1210/er.2007-0034

31. Augustina MA, Biessels GJ, De Haan EH, et al. The effects of type 1 diabetes on cognitive performance a meta-analysis. Diabetes Care. 2005;28(3):726–735. doi: 10.2337/diacare.28.3.726

32. Vanhanen M, Soininen H. Glucose intolerance, cognitive impairment and Alzheimer’s disease. Curr Opin Neurol. 1998;11(6):673–677. doi: 10.1097/00019052-199812000-00011